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A B S T R A C T
Photosensitivity in childhood is caused by a diverse group of diseases. A specific sensitivity of a child’s skin to ultravi-
olet light is often the first manifestation or a clinical symptom of photodermatosis. It might indicate a serious underlying
systemic disease such as lupus erythematosus or dermatomyositis, or a rare group of genetic skin disorders like Xero-
derma pigmentosum, Cockayne syndrome, Trichothyodystrophy, Bloom syndrome, Rothmund-Thomson and Kindler
syndrome as well as metabolic disorders and cutaneous porphyria. Photosensitivity secondary to topical or systemic
agents may also cause photosensitivity in children. Early recognition and prompt diagnosis may prevent complications
associated with unprotected exposure to sunlight and avoid actinic injuries that can leed to malignant skin changes.
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Introduction
Light induced skin eruptions are not a common prob-
lem in pediatric dermatology. The incidence of photo-
sensitivity disorders in the pediatric age group is much
lower than in adults1. In contrast to adults, the bulk of
photosensitive children are included under the group of
metabolic and genetic disorders and pose a diagnostic
challenge2. Most childhood photodermatoses are suffi-
ciently characteristic that history and examination often
suffice to identify a probable diagnosis. A systematic ap-
proach with a detailed history of the age of onset, the
chronological order of appearance of symptoms associ-
ated with clinical examination and investigations are
helpfull in such cases3. The age of onset of photosen-
sitivity and related skin lesions helps in diagnosis differ-
ent disorders. Most of the genodermatoses and a few rare
types of porphyrias manifest during infancy. Idiopathic
photodermatoses usually affect older children. Genoder-
matoses and metabolic disorders may have associated
systemic involvement. Systemic abnormalities such as
neurologic dysfunction, mental retardation, and hepato-
splenomegaly may be associated features of several pho-
tosensitivity syndromes of children4.
Classification of photodermatoses
Classification of the photodermatoses is based on the
cause of the disorder and on the pathology of cutaneous
response. Observation of the clinical patterns of reactiv-
ity of the skin and the timing of the response helps the
clinician to classify this disorders5. Photodermatoses can
be classified into five general categories: 1) immunologi-
cally mediated photodermatoses, or idiopathic, including
polymorphic light eruption (PMLE), actinic prurigo (AP),
hydroa vacciniforme (HV) and solar urticaria (SU); 2)
photodermatoses which are secondary to exogenous age-
nts, including phototoxic and photoallergic reactions; 3)
photoexacerbated dermatoses, including autoimmune di-
sease, infectious conditions, and nutritional deficiencies;
4) photodermatoses secondary to endogenous agents,
mainly the porphyrias; and 5) genodermatoses6.
Immunologically mediated photodermatoses
(idiopathic)
The immunologically mediated photodermatoses (IMP,
previous term: idiopathic photodermatoses) represent a
heterogenous group of disorders presenting with patho-
logic skin reactions caused by optical radiation, particu-
larly in the UVA wavelength region7.
Polimorphous light eruption (PLE) is the commonest
photodermatosis in childhood, with prevalence of as high
as 10–20%. PLE lesions usually appear 2 hours to 3 days
following sun exposure and persist for several days or
weeks. PLE is characterised clinically by the occurence of
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non-scarring, pruritic, erythematous papules, papulove-
sicles, vesicles or plaques on sun-exposed skin areas8,9.
Currently, a delayed-type immunoreaction induced by ul-
traviolet raditation (UVR) and maintained by defective
immunoregulatoy mechanism is proposed as the patho-
genesis of PLE10. A particular type of PLE in 5–12
year-old boys is previously termed „juvenile spring erup-
tion«. Here, reccurent episodes of an itchy papulo-vesicu-
lar eruption occur over the helices of the ears, followed
by crusting and healing without scarring11. There are no
diagnostic laboratory tests available for PLE, thus labo-
ratory examinations are usually performed to exclude
other dermatoses such as photosensitive lupus erythe-
matosus or erythropoietic protoporphyria. Persistent pla-
que-type of PLE must also be differentiated from Je-
ssner-Kanof’s lymphocytic infiltration of the skin9. Pru-
ritus occuring within hours with the same time course
ase polymorphous light eruption (PLE) has been de-
scribed PLE sine eruptione12.
Solar urticaria is a rare, acute urticarial reaction on
both sun-exposed and covered skin areas, which appears
soon after exposure to sun or artificial lighting13. Typical
urticarial wheals appear within seconds to minutes fol-
lowing sun exposure. They generally resolve within 1–2
hours of avoidance of sun exposure14. Sunlight induced
urticaria may be a symptom of erythropoietic proto-
porphyria (EPP), but the latter starts at an earlier age,
family history is often positive and the skin lesions are
painful15. In solar urticaria, the proposed pathogenesis is
an immediate-type hypersensitivity reaction. A precur-
sor (cromophore) is activated by electromagnetic irradia-
tion, thus forming a photoproduct (photoallergen). Spe-
cific IgE directed against the photallergen is bound to the
surface of mast cells10.
Actinic prurigo(AP) is commoner in girls and mani-
fests by 9–10 years of age as pruritic excoriated papules
and nodules on exposed parts. Associated conjuctivitis
and actinic cheilitis are characteristic8,16.
Hydroa vacciniforme (HV) is a very rare condition
mostly seen among young boys in a sun exposed distribu-
tion which tends to heal sontaneously during adoles-
cence1,13. Reccurent crops of vesicles with surrounding
erythema appear on exposed body parts within 1–2 days
after sun exposure and heal with pock-like scars13. HV is
a rare childhood disorder mainly induced by UVA. The
major differential diganosis includes EPP, vesicular PLE,
AP, Hartnup’s disease and bullous LE17,18. PLE, SU, AP
and HV have overlapping clinical pictures but can be dis-
tinguished easily3.
Photosensitivity secondary to exogenous
agents
In general, childhood photosensitization by external
chemicals or internal medication is rather rare19.
Phototoxic dermatitis is caused by external agents ei-
ther systemic, or topically applied which predictably
lower threshold for abnormal UVR (ultraviolet radia-
tion) responses13. In the most common phototoxic der-
matitis with erythema, edema and sometimes blisters,
the provoking agents in childhood are usually psora-
len-containing plants (phytophotodermatitis)1,13. Citrus
fruits, lime juice, mango and extracts of a few common
weeds containing furocoumarins are common sensitizing
agents in shool-going children13.
Pseudoporphyria is a bullous photosensitivity disor-
der that clinically and histologically mimics porphyria
cutanea tarda (PCT), whith no demonstrable porphyrin
abnormalities20,21. Pseudoporphyria is clinically charac-
terized by increased skin fragility, erythema, and the ap-
pearance of tense bullae and erosions with scarring on
sun-exposed skin21. Pseudoporphyria is a common side
effect with facial scarring of naproxen therapy in chil-
dren with juvenile rheumatoide arthritis22.
Drug-induced photosensitivity reactions refer to the
development of cutaneous disease as a result of the com-
bined effects of a drug and light (mostly spectrum within
the UVA and visible light range or UVB range). Drugs
such as furosemide, nalidixic acid and quinolones pro-
duce often blistering in sunlight23.
Photoallergic disorders are skin lesions occur follow-
ing sun exposure, and are characterized by activation of
immunological mechanisms, involving photosensitizers
and photoallergens that can cause photosensibilization
in some individuals13. They are less common than pho-
totoxic reactions and are determined by either delayed
hypersensitivity responses or more rarely immediate hy-
persensitivity reactions mediated by IgE in response to
UVR. Several therapeutic agents may give rise to both
phototoxic and photoallergic reactions. Many disorders
develop potoadaptation; thus, the patient and clinician
may be missed by the fact that the face is unaffected, but
sites only occasionally exposed to the sun are worst
affected5.
Photoexacerbated / agravated disorders
The diverse group of photoexacerbated/aggravated
disorders occur independently of enviromental UVR ex-
posure, but may be worsened by exposure to UVR; such
as cutaneous lupus erithemathosus (LE) and dermato-
myositis1,24. Cutaneous LE is frequently photoaggrava-
ted, this is usually associated with positive Ro and La an-
tibodies. These keratinocyte-expressed nuclear antigens
are exteriorized by UVR, and cytotoxic antibodies di-
rected against the Ro antigen react directly with the an-
tigen leading to cell death and inflammation. Many pa-
tients with LE exhibit a rash identical in morphology to
PLE. Thus, the only way of determining whether a pa-
tient has PLE is by excluding LE on serology, by checking
anti-nuclear antibody (ANA), extractable nuclear anti-
gen (ENA), complement (C3,C4) and buy direct immu-
nofluorescence25,26.
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Cutaneous porphyrias
Porphyria is a predominantly inherited metabolic dis-
order, resulting from a deficiency of an enzyme in the
heme production pathway and overproduction of toxic
heme precursors27. It is the most common inherited
cause of photosensitivity, which can arise in childhood28.
Erythropoietic protoporphyria (EPP) is the most com-
mon childhood porphyria manifested in early infancy,
and ussualy transmitted in an autosomal dominant man-
ner. A heterogeneous group of mutations in the gene of
ferrochelatase has been detected29. Immediate photo-
sensitivity manifest as a painful swelling with erythema,
urticaria or blisters healing with scars. With the progres-
sion of the disease, characteristic chronic skin symptoms
(waxy thickening of the sun-exposed skin and orange
peel appearance of the nose) appear30.
Porphyria cutanea tarda (PCT) results from decrea-
sed hepatic uroporphyrinogen decarboxylase (UROD) ac-
tivity. In the majority of patients, the disease is sporadic
(S-PCT or type I) and the enzyme deficiency is limited to
the liver. The principal clinical manifestation of PCT are
cutaneous photosensitivity leadng to blistering in areas
exposed to sun, skin fragility, hyperpigmentation and
hypertrichosis31. Familial porphyria cutanea tarda (F-PCT
or type II) may arise in the first decade of life, similar to
its extremely rare homozygous form called hepatoery-
thropoietic porphyria (HEP)32. F-PCT is observed in
20–30% of patients in whom mutations on one allele of
the UROD gene reduce UROD activity by approximately
50% in all tissues33.
Congenital erythropoietic porphyria (CEP) (CEP, Gün-
ther’s disease) is an extremely rare autosomal recessive
disease, characterized by mutilating cutaneous photo-
sensitivity and abnormal haem synthesis in the bone
marrow with reduced activity of uroporphyrinogen III
synthase. Clinical manifestations can range from mild to
severe and include erythrodontia, reddish-colored urine,
and hemolytic anemia that can be mild or severe and
may result in splenomegaly34.
All photosensitive children without definitive clinical
diagnosis should be evaluated for antinuclear (ANA),
anti-Ro(SSA), andi anti-La (SSB) antibodies and por-
phyrin levels. Wood’s lamp examination helps in demon-
strating erythrodontia in CEP and HEP. Skin biopsy is
helpful in idiopathic photodermatoses and porphyrias
(deposition of PAS positive porphyrins in a perivascular
distribution is characteristic35.
Genophotodermatoses
Hereditary photodermatoses are characterized by an
increased photosensitivity caused by an inherited single
gene defect. With few exceptions, they manifest in early
childhood, reveal heterogeneous clinical symptoms, and
are difficult to treat. Although these diseases are rare, it
is very important to make an accurate diagnosis on the
basis of clinical symptoms, specific diagnostic tests, and
direct DNA analysis36.Besides the characteristic skin
symptoms, these disorders are usually associated with an
early develoopment of cutaneous and ocular malignan-
cies as well as specific extracutaneous features1,19. Xero-
derma pigmentosum (XP), trichothiodystrophy (TTD)
and Cockayne syndrome (CS) are rare, inherited neuro-
cutaneous disorders characterized by skin hypersensitiv-
ity to sun exposure in association with abnormalities in
the nervous system. These autosomal recessive diseases
are caused by defects in nucleotide excision repair (NER)37.
Xeroderma pigmentosum (XP) is an autosomal reces-
sive disease, characterized by an abnormal sensitivity to
sunlight, freckling, premature skin ageing and multiple
neoplasia.
Most patients have a defective NER of UV-damaged
DNA due to the lack of specific UV-endonuclease38.
Bloom syndrome(congenital telangiectatic erythema)
is a rare autosomal recessive disorder characterized by
telangiectases and photosensitivity, growth deficiency of
prenatal onset, variable degrees of immunodeficiency,
and increased susceptibility to neoplasms of many sites
and types39. It is caused by a mutation in the gene desig-
nated BLM, traced to band 15q26.1. The protein encoded
by the normal gene has DNA helicase activity and func-
tions in the maintenance of genomic stability40.
Rothmund-Thomson syndrome, or poikiloderma con-
genitale, is a rare autosomal recessive disorder attrib-
uted to mutations of the RECQL4 helicase gene on 8q24.
Key features include early photosensitivity and poikilo-
dermatous skin changes, juvenile cataracts, skeletal dys-
plasias, and a predisposition to osteosarcoma and skin
cancer41,42.
Kindler syndrome is an autosomal recessive geno-
dermatosis characterized by poikiloderma, skin atrophy,
trauma-induced skin blistering, mucosal inflammation,
and photosensitivity. The molecular pathology of Kindler
syndrome involves loss-of-function mutations in a newly
recognized actin cytoskeleton-associated protein, now
known as fermitin family homologue 1, encoded by the
gene FERMT143.Although Kindler syndrome is classified
as a subtype of epidermolysis bullosa, it has distinct
clinicopathological and molecular abnormalities. During
infancy and childhood, there is clinical overlap between
Kindler syndrome and dystrophic epidermolysis bullosa
(EB)44.
Conclusion
The initial step in evaluating a photosensitive patient
is based on a directed personal and family history. The
morphology of the eruption, phototests, and in some pa-
tients, photopatch tests are essential in focusing the di-
agnosis. Skin biopsies and laboratory investigations, such
as antinuclear antibody (ANA) panels and porphyrin
profiles, may be required to further confirm the diagno-
sis. Early recognition and prompt diagnosis may prevent
complications associated with unprotected exposure to
sunlight and avoid actinic injuries that can leed to malig-
nant skin changes.
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FOTODERMATOZE U DJETINJSTVU
S A @ E T A K
Pojava fotodermatoza u djetinjstvu mo`e biti uzrokovana razli~itim grupama bolesti pri ~emu je poja~ana specifi~na
senzitivnost dje~je ko`e na ultraljubi~asto svijetlo ~esto prvi klini~ki simptom. Ko`ne promjene mogu biti prvi znak
sistemske bolesti kao {to je lupus erythematosus ili dermatomiozitis, ili rijetke grupe genetskih bolesti koje uklju~uju
porfirije, xerodermu pigmentosum, Cockayne sindrom, Bloom sindrom, Rothmund-Thomson sindrom, te Kindler sin-
drom, kao i metaboli~ke bolesti sa sistemskim manifestacijama. Fotosenzitivnost mo`e biti i posljedica primjenjenog
lokalnog pripravka ili sistemskih lijekova. Rano prepoznavanje i brza dijagnoza mogu sprije~iti komplikacije kao pos-
ljedice neza{ti}enog izlaganja sun~evom svijetlu te sprije~iti aktini~ku ozljedu ko`e koja mo`e voditi pojavi zlo}udnih
ko`nih promjena.
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